Chirogate International is an API manufacturer based in Taiwan. It holds 13 active US drug master files across a filed portfolio of 11 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 29 July 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Taiwan, Taiwan | 3006560887 |
| Molecule | Regulators | Docs |
|---|---|---|
| Travoprost | US FDA | 2 |
| Treprostinil | US FDA | 2 |
| Bimatoprost | US FDA | 1 |
| Carboprost | US FDA | 1 |
| Dinoprostone | US FDA | 1 |
| Iloprost | US FDA | 1 |
| Latanoprost | US FDA | 1 |
| Latanoprostene Bunod | US FDA | 1 |
| Tafluprost | US FDA | 1 |
| Treprostinil Palmitil | US FDA | 1 |
| Unoprostone | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 1 | None |
| US FDA | None | 1 |
Choose your molecules and target markets. Chirogate International comes back tiered against every other supplier able to file there.
Start for free